Understanding the role of B cells in atherosclerosis: potential clinical implications

A Systems Biology Framework Identifies Molecular Underpinnings of Coronary Heart Disease

(2013) Tianxiao Huan et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Cardiovascular disease in autoimmune rheumatic diseases

(2013) Ivana Hollan et al.   AUTOIMMUNITY REVIEWS

Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype

(2013) K. Covens et al.   BLOOD

Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis

(2013) Gregor Leibundgut et al.   CURRENT OPINION IN PHARMACOLOGY

Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans

(2013) Peter Libby et al.   IMMUNITY

Adaptive immunity in atherogenesis: new insights and therapeutic approaches

(2013) Andrew H. Lichtman et al.   JOURNAL OF CLINICAL INVESTIGATION

Characterization of Resident B Cells of Vascular Walls in Human Atherosclerotic Patients

(2013) M. Hamze et al.   JOURNAL OF IMMUNOLOGY

Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure

(2013) F. K. Swirski et al.   SCIENCE

B cell subsets in atherosclerosis

(2013) Heather Perry   Frontiers in Immunology

HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab

(2012) Hennie G Raterman et al.   ANNALS OF THE RHEUMATIC DISEASES

Immune Regulatory Function of B Cells

(2012) Claudia Mauri et al.   Annual Review of Immunology

BAFF Receptor Deficiency Reduces the Development of Atherosclerosis in Mice—Brief Report

(2012) Andrew P. Sage et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice

(2012) Olivier Herbin et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

(2012) Brad H. Rovin et al.   ARTHRITIS AND RHEUMATISM

In search of a marker of vulnerable carotid plaque: Is the key in the heart?

(2012) Mario Petretta et al.   ATHEROSCLEROSIS

Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography

(2012) Yaron Arbel et al.   ATHEROSCLEROSIS

Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis – A review of the experimental evidence

(2012) Harry Björkbacka et al.   ATHEROSCLEROSIS

Properties of mouse and human IgG receptors and their contribution to disease models

(2012) P. Bruhns   BLOOD

Lymphocytes and the Adventitial Immune Response in Atherosclerosis

(2012) Kirsti A. Campbell et al.   CIRCULATION RESEARCH

To B or Not to B the Conductor of Rheumatoid Arthritis Orchestra

(2012) Rita A. Moura et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Role of colony-stimulating factors in atherosclerosis

(2012) Karina Di Gregoli et al.   CURRENT OPINION IN LIPIDOLOGY

Routine laboratory tests to risk-stratify patients with chronic coronary artery disease

(2012) Francesco Sbrana et al.   Journal of Cardiology

Gene profiling of CD11b+and CD11b−B1 cell subsets reveals potential cell sorting artifacts: Figure 1.

(2012) Claude-Agnès Reynaud et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues

(2012) Lawrence J. Laslett et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Unknown

(2012) Daniel Griffin et al.   MOLECULAR MEDICINE

Depletion of B2 but Not B1a B Cells in BAFF Receptor-Deficient ApoE−/− Mice Attenuates Atherosclerosis by Potently Ameliorating Arterial Inflammation

(2012) Tin Kyaw et al.   PLoS One

No significant change in arterial stiffness in RA after 6 months and 1 year of rituximab treatment

(2012) S. Mathieu et al.   RHEUMATOLOGY

Innate Response Activator B Cells Protect Against Microbial Sepsis

(2012) P. J. Rauch et al.   SCIENCE

Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity

(2012) YK Onno Teng et al.   ARTHRITIS RESEARCH & THERAPY

Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis

(2012) Natalie A Carter et al.   ARTHRITIS RESEARCH & THERAPY

Human B1 Cell Frequency: Isolation and Analysis of Human B1 Cells

(2012) Daniel O. Griffin et al.   Frontiers in Immunology

Recent Advances on the Role of Cytokines in Atherosclerosis

(2011) Hafid Ait-Oufella et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trial

(2011) Maria W. Greenwald et al.   ARTHRITIS AND RHEUMATISM

A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis

(2011) Michael C. Sneller et al.   ARTHRITIS AND RHEUMATISM

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

(2011) S. De Vita et al.   ARTHRITIS AND RHEUMATISM

Developmental relationships between B-1 and B-2 progenitors

(2011) Chad L. Barber et al.   CELL CYCLE

B1a B Lymphocytes Are Atheroprotective by Secreting Natural IgM That Increases IgM Deposits and Reduces Necrotic Cores in Atherosclerotic Lesions

(2011) Tin Kyaw et al.   CIRCULATION RESEARCH

B-Cell Aortic Homing and Atheroprotection Depend on Id3

(2011) Amanda C. Doran et al.   CIRCULATION RESEARCH

A human equivalent of mouse B-1 cells?: Figure 1.

(2011) Marc Descatoire et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The nature of circulating CD27+CD43+B cells: Figure 1.

(2011) Martin Perez-Andres et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70−

(2011) Daniel O. Griffin et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The immune system in atherosclerosis

(2011) Göran K Hansson et al.   NATURE IMMUNOLOGY

Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets

(2011) Charlotte Lahoute et al.   Nature Reviews Cardiology

B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer

(2010) David J. DiLillo et al.   Annals of the New York Academy of Sciences

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

(2010) P. Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

(2010) P. P. Tak et al.   ANNALS OF THE RHEUMATIC DISEASES

Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial

(2010) J. M. Meijer et al.   ARTHRITIS AND RHEUMATISM

Id3 Is a Novel Atheroprotective Factor Containing a Functionally Significant Single-Nucleotide Polymorphism Associated With Intima–Media Thickness in Humans

(2010) Amanda C. Doran et al.   CIRCULATION RESEARCH

Atherosclerotic lesions in mouse and man: is it the same disease?

(2010) Jacob Fog Bentzon et al.   CURRENT OPINION IN LIPIDOLOGY

CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

(2010) Paul A. Blair et al.   IMMUNITY

Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study)

(2010) Fereydoun DAVATCHI et al.   International Journal of Rheumatic Diseases

Natural IgM Antibodies Against Oxidation-Specific Epitopes

(2010) Christoph J. Binder   JOURNAL OF CLINICAL IMMUNOLOGY

B cell depletion reduces the development of atherosclerosis in mice

(2010) Hafid Ait-Oufella et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Conventional B2 B Cell Depletion Ameliorates whereas Its Adoptive Transfer Aggravates Atherosclerosis

(2010) T. Kyaw et al.   JOURNAL OF IMMUNOLOGY

Comment on "Conventional B2 B Cell Depletion Ameliorates whereas Its Adoptive Transfer Aggravates Atherosclerosis"

(2010) M. J. Lipinski et al.   JOURNAL OF IMMUNOLOGY

Cutting Edge: Novel Function of B Cell-Activating Factor in the Induction of IL-10-Producing Regulatory B Cells

(2010) M. Yang et al.   JOURNAL OF IMMUNOLOGY

Regulatory B cells: Evidence, developmental origin and population diversity

(2010) Gaetano Vitale et al.   MOLECULAR IMMUNOLOGY

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

Leukocytosis as a predictor for non-infective mortality and morbidity

(2010) K. Asadollahi et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Immunoglobulin M Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice

(2009) Myles J. Lewis et al.   CIRCULATION

Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis

(2009) György Kerekes et al.   CLINICAL RHEUMATOLOGY

Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans

(2009) Meng-Yun Chou et al.   JOURNAL OF CLINICAL INVESTIGATION

Lymphotoxin β receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of agedApoE−/−mice

(2009) Rolf Gräbner et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Identification and Characterization of a Human CD5+ Pre-Naive B Cell Population

(2009) J. Lee et al.   JOURNAL OF IMMUNOLOGY

Relationship of Oxidized Phospholipids and Biomarkers of Oxidized Low-Density Lipoprotein With Cardiovascular Risk Factors, Inflammatory Biomarkers, and Effect of Statin Therapy in Patients With Acute Coronary Syndromes

(2009) Alexander E. Fraley et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

(2009) Mark D. Pescovitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

(2009) Dimitrios Daoussis et al.   RHEUMATOLOGY

Helminth infections associated with multiple sclerosis induce regulatory B cells

(2008) Jorge Correale et al.   ANNALS OF NEUROLOGY

Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study

(2008) S Dass et al.   ANNALS OF THE RHEUMATIC DISEASES

Atherosclerosis in Autoimmune Rheumatic Diseases—Mechanisms and Clinical Findings

(2008) Hasya Zinger et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Peripheral B cell subsets

(2008) David Allman et al.   CURRENT OPINION IN IMMUNOLOGY

Relationship Between Biomarkers of Oxidized Low-Density Lipoprotein, Statin Therapy, Quantitative Coronary Angiography, and Atheroma Volume

(2008) Seung Hyuk Choi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Plasma Interleukin-5 Levels Are Related to Antibodies Binding to Oxidized Low-Density Lipoprotein and to Decreased Subclinical Atherosclerosis

(2008) Maritta Sämpi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Nonclinical Safety, Pharmacokinetics, and Pharmacodynamics of Atacicept

(2008) Michela Carbonatto et al.   TOXICOLOGICAL SCIENCES